Europe climbs as the FTSE falls

As European leaders have started the latest EU summit discussions, European equity traders have cautiously headed higher while FTSE traders have fallen away.

Source: Bloomberg

The FTSE 100 has spent all day struggling to keep up with the rest of the European equity markets. In fairness the FTSE has been hampered from the start, dropping 24 points due to such heavy weights as AstraZeneca, GlaxoSmithKline and Shell all going ex-dividend today. In contrast, the DAX has once again shown the form that has led it to be one of the best performing indices in Europe since the financial crisis.

Part of the reason why the FTSE has struggled has been the ongoing discussions that David Cameron has been having in Brussels with his European counterparts. The success of these meetings could go a long way in dictating how the UK perceives the value of remaining in the EU.

A reflection of how important this is to the eurozone can be gauged from the comments of EC President Jean-Claude Junker, 'I’m quite confident that we will have a deal', as well as Angela Merkel, 'keeping Britain in the EU is not just in Britain’s but also in Germany’s interest, and that of Europe as a whole.'

With this being the case, it is likely that if push comes to shove the EU members will show increasing flexibility in order to help maintain the status quo. The IG Brexit digital 100s binary still gives a 67% chance of the UK voting to stay inside the EU.

Regardless of the fact that Iran and Iraq agreed to nothing yesterday, and the terms of the Saudi-Russian discussions the previous day would do little to alter the supply/demand imbalance, oil prices have climbed by over 2.5% today.

Gold has also shown some resilience up by 0.5%, and is now trading around $1215, giving the gold bugs some hope that last week’s brief trip above $1250 was more than just a one off. A close above $1214 could pave the way for a fresh move up to $1232 and then onto $1263.

FTSE 100 risers and fallers (as of 4.30pm) 

Company % change Index points
Centrica +6.85 +2.62
National Grid +0.92 +1.29
International Consolidated Airlines Group +2.56 +0.97
BT Group +0.62 +0.93
BAE Systems +1.14 +0.7


Company % change Index points
GlaxoSmithKline -3.09 -8.35
Royal Dutch Shell A -3.23 -8.15
Royal Dutch Shell B -3 -7.54
AstraZeneca -3.51 -7.39
HSBC -1.77 -6.17

The day ahead

Economic data:

5am – Bank of Japan monthly report: traders will be looking for clarification as to why the BoJ introduced negative interest rates.

9.30am – UK retail sales and core retail sales (January): retail sales MoM expected 0.7%, prior -1% and YoY expected 3.5%, prior 2.6%. Core retail sales: MoM expected 0.7%, prior -0.9% and YoY expected 3.5%, prior 2.1%.

1.30pm – US CPI and core CPI (January): inflation is expected to increase to 0.03% from -0.1% MoM and tick up to 0.76% to 0.7% YoY. Core inflation is anticipated to rise to 0.2% from 0.1% MoM, and hold steady at 2.1% YoY.

1.30pm – Canada CPI and core CPI (January): the forecast is for MoM CPI to come in at 0.1%, from -0.5% and the YoY reading is anticipated to be 1.67%, up from 1.6%. Core CPI is expected to rise to 0.2% from -0.4% MoM, and remain at 1.9% YoY.

Corporate reporting:

Standard Life, Segro, Allianz, Coca-Cola Co Deere & Co

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.